Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP906803.RAqced1_R52c1WuyCj1uRKy5ai1T0_tWYCCQInmMnW_wc130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP906803.RAqced1_R52c1WuyCj1uRKy5ai1T0_tWYCCQInmMnW_wc130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP906803.RAqced1_R52c1WuyCj1uRKy5ai1T0_tWYCCQInmMnW_wc130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP906803.RAqced1_R52c1WuyCj1uRKy5ai1T0_tWYCCQInmMnW_wc130_provenance.
- NP906803.RAqced1_R52c1WuyCj1uRKy5ai1T0_tWYCCQInmMnW_wc130_assertion description "[We show that quinacrine synergizes with 5-fluorouracil and significantly enhances the cytotoxicity of sorafenib in a panel of 10 human colorectal cancer cell lines, including those with KRAS mutations protein gel blot analysis confirmed that quinacrine's anticancer activity partially arises from its ability to stabilize p53 and lower anti-apoptotic protein levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP906803.RAqced1_R52c1WuyCj1uRKy5ai1T0_tWYCCQInmMnW_wc130_provenance.
- NP906803.RAqced1_R52c1WuyCj1uRKy5ai1T0_tWYCCQInmMnW_wc130_assertion evidence source_evidence_literature NP906803.RAqced1_R52c1WuyCj1uRKy5ai1T0_tWYCCQInmMnW_wc130_provenance.
- NP906803.RAqced1_R52c1WuyCj1uRKy5ai1T0_tWYCCQInmMnW_wc130_assertion SIO_000772 21725213 NP906803.RAqced1_R52c1WuyCj1uRKy5ai1T0_tWYCCQInmMnW_wc130_provenance.
- NP906803.RAqced1_R52c1WuyCj1uRKy5ai1T0_tWYCCQInmMnW_wc130_assertion wasDerivedFrom befree-2016 NP906803.RAqced1_R52c1WuyCj1uRKy5ai1T0_tWYCCQInmMnW_wc130_provenance.
- NP906803.RAqced1_R52c1WuyCj1uRKy5ai1T0_tWYCCQInmMnW_wc130_assertion wasGeneratedBy ECO_0000203 NP906803.RAqced1_R52c1WuyCj1uRKy5ai1T0_tWYCCQInmMnW_wc130_provenance.
- befree-2016 importedOn "2016-02-19" NP906803.RAqced1_R52c1WuyCj1uRKy5ai1T0_tWYCCQInmMnW_wc130_provenance.